Medallion
Medallion provides a platform for healthcare organizations to automate provider credentialing, payer enrollment, license verification, and compliance monitoring.
Secondary Market Price
Secondary Market Price
How Medallion Measures Up
To help you manage your Medallion equity, Prospect has run the company through our machine learning model.
Prospect Rating
2X
Our rating indicates that Medallion could be worth at least double its current value. For employees with equity, this suggests a potential for their stock to also double in value.
Exit Risk
Moderate Risk
Our 'Moderate Risk' rating for Medallion signifies that despite its rapid scaling and backing from top investors, there is a medium likelihood it will not reach a liquidity event compared to other startups due to its current growth stage and market competition.
Funding Stage
Series D
For a potential employee, a Series D company like Medallion is well past its initial startup phase, offering more stability and proven market traction. This means you'd be joining a more established organization with structured roles and a clear growth trajectory, rather than an early-stage venture still finding its footing.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Medallion's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Medallion Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Medallion's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Medallion provides a provider network operations platform for healthcare organizations that automates and streamlines administrative tasks. The company’s services focus on credentialing, payer enrollment, state licensure, and ongoing compliance monitoring. Its platform uses cloud-based workflows to automate primary source verification, manage applications, and provide analytics dashboards for clients that include digital health companies, provider groups, and health systems. Founded in 2019 by Derek Lo and headquartered in San Francisco, Medallion has grown to serve over 300 healthcare organizations. The company has raised approximately $130 million in funding from investors that include Sequoia Capital, Google Ventures, and Optum Ventures.
The company’s stated goal is to build out the digital infrastructure for healthcare to reduce administrative burdens. Medallion is actively hiring to support its growth and participates in industry events to showcase its technology, including a planned session on AI-driven automation at the HLTH 2025 conference. Recent developments include being named to the 2025 LinkedIn Top Startups List in the U.S. for the second consecutive year. The company also recently published an analysis of more than 64,000 payer enrollment submissions to highlight regional differences in provider onboarding and revenue cycles.
- Sequoia Capital
- GV
- Salesforce Ventures
- BoxGroup
- Elad Gil
- Acrew Capital
- Optum
- Founder, CEO Derek Lo
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Medallion worth joining?
As a rapidly growing Series C startup backed by top investors, Medallion presents a compelling opportunity in the healthcare technology space. Platforms like Prospect can help you analyze data on the company's growth and risk profile to make an informed decision.
What should I do with my Medallion stock?
Managing equity in a private company like Medallion involves understanding your grant, vesting schedule, and potential tax implications. Prospect offers tools to help you forecast your stock's value and develop an optimal strategy for your financial goals.
Can you sell Medallion stock?
As a private company, Medallion stock is not publicly traded, so selling is generally restricted to company-approved liquidity events like tender offers. When such opportunities arise, tools from platforms like Prospect can help you determine how much to sell and which shares are most tax-optimal.
How can I find the value of my Medallion stock?
The value of private stock is based on the company's most recent valuation, which for Medallion was $350M in its last funding round. To estimate future worth, you can use platforms like Prospect that provide predictive models for private company equity.
What is Medallion's equity worth?
Medallion's latest company valuation is $350M, based on its Series C funding round. The value of an individual's equity stake is a percentage of this total valuation, determined by the number of shares they hold.
What is Medallion's stock ticker symbol?
Medallion is a private company, so it is not listed on a public stock exchange and does not have a stock ticker symbol. Ticker symbols are exclusively for publicly traded securities.
Can I buy or sell Medallion stock?
Since Medallion is a private company, its stock is not available for purchase on public markets, and selling is typically restricted. Buying shares is usually limited to accredited investors during funding rounds, while selling opportunities for employees may occur during tender offers.
What is the criteria to buy or invest in Medallion stock?
Investing in a private, venture-backed company like Medallion is typically reserved for institutional or accredited investors participating in formal funding rounds. There are no established criteria for the general public to purchase shares at this time.
